Privia Health Group Inc (PRVA) Stock Analysis
Verdict: WATCH (do not buy)
Robust FCF and zero net debt support 20%+ growth, but razor-thin 1.2% net margins and insider selling cap immediate valuation upside.
Investment score: 59/100
Analysis as of
Is Privia Health Group Inc stock worth reviewing? The TradeMates thesis
TradeMates sees Privia Health as a high-quality value-based care platform with excellent cash conversion, but high valuation multiples and net margins near 1.2% keep the risk/reward balanced near current levels.
7-factor investment score
- Valuation: 48/100 (weight 20%)
- Financial Health: 78/100 (weight 15%)
- Technical Momentum: 58/100 (weight 15%)
- Earnings Quality: 50/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 85/100 (weight 10%)
- Risk-Adjusted Return: 68/100 (weight 15%)
Privia Health Group Inc opportunities and risks
What speaks for PRVA
- Exceptional Free Cash Flow Generation and Asset-Light Model
What speaks against PRVA
- Razor-Thin Profit Margins Leave Zero Room for Execution Errors
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PRVA | 101.8x | 1.2x | n/a | 7.6% | 1.2% | -1.7% |
| BLLN | 153.1x | 12.5x | 91.2x | 71.3% | 8.4% | 0.7% |
| LFST | 96.5x | 3.0x | 36.3x | 33.6% | 3.2% | 4.4% |
| OPCH | 23.5x | 0.8x | 13.9x | 18.2% | 3.7% | 7.4% |
| CRVL | 37.3x | 4.3x | 21.8x | 23.9% | 11.7% | 2.7% |
| AVAH | 10.0x | 1.1x | 14.0x | 32.0% | 10.6% | 5.7% |
| Peer median | 37.3x | 3.0x | 21.8x | 32.0% | 8.4% | 4.4% |
Frequently asked questions about Privia Health Group Inc (PRVA)
Is PRVA stock a good investment?
The TradeMates model rates Privia Health Group Inc as WATCH (do not buy) with an investment score of 59/100. TradeMates sees Privia Health as a high-quality value-based care platform with excellent cash conversion, but high valuation multiples and net margins near 1.2% keep the risk/reward balanced near current levels. This is algorithmic model output, not personal investment advice.
Is PRVA stock a buy?
The TradeMates model verdict for PRVA is WATCH (do not buy) with an investment score of 59/100. Treat this as a model signal to review, not a personal buy recommendation.